{
    "eid": "2-s2.0-85079228580",
    "title": "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde",
    "cover-date": "2020-05-27",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "inflammation",
        "neuro-immune",
        "nitrosative stress",
        "Schizophrenia",
        "tryptophan catabolites"
    ],
    "authors": [
        "Michael Maes",
        "Sunee Sirivichayakul",
        "Buranee Kanchanatawan",
        "Andr\u00e9 F. Carvalho"
    ],
    "citedby-count": 12,
    "ref-count": 72,
    "ref-list": [
        "Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides",
        "Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment, and neuroprogression",
        "The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations",
        "Prefrontal Cortex: Structure and Anatomy",
        "Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder",
        "Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis",
        "Indirect evidence for nitricoxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine",
        "Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis",
        "Cognition in young schizophrenia outpatients: comparison of first-episode with multi-episode patients",
        "Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia",
        "An investigation into movement planning and execution deficits in individuals with schizophrenia",
        "The relationship between executive function and fine motor control in young and older adults",
        "Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis",
        "A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis",
        "Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries",
        "Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease",
        "Objectively measurable equilibriometric locomotor ataxia in schizophrenia",
        "Anti-phosphoinositide auto-antibodies in sera of cancer patients: isotypic and immunochemical characterization",
        "Concurrent performance of motor tasks and processing capacity in patients with schizophrenia",
        "Prefrontal Cortex",
        "Identification of antibodies in sera of breast cancer patients",
        "Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder",
        "Psychomotor planning is deficient in recent-onset schizophrenia",
        "Psychomotor Disorders in Schizophrenia: A Systematic Review",
        "A rating scale for depression",
        "Computerized ultrasonographic craniocorpography and abnormal psychomotor activity in psychiatric patients",
        "Objective and quantitative equilibriometric evaluation of individual locomotor behaviour in schizophrenia: Translational and clinical implications",
        "Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?",
        "Systems neuroplasticity in the brain: Recruiting additional neural resources for successful motor performance in elderly persons",
        "Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons",
        "Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms",
        "Psychomotor slowing and planning deficits in schizophrenia",
        "Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis",
        "In schizophrenia, depression, anxiety, and physiosomatic symptoms are strongly related to psychotic Symptoms and Excitation, impairments in episodic memory, and increased production of neurotoxic tryptophan catabolites: a multivariate and machine learning study",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "The validity of the Mini International Neuropsychiatric Interview (M.I.N.I.) Thai Version",
        "Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum",
        "Thinking, walking, talking: integratory motor and cognitive brain function",
        "Cortical mechanisms of feature-based attentional control",
        "In vivo immunomodulatory effects of clozapine in schizophrenia",
        "Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs",
        "The Compensatory Immune-Regulatory Reflex System (CIRS) in depression and bipolar disorder",
        "Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs",
        "In schizophrenia, deficits in natural igm isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome",
        "Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine",
        "Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression",
        "Trail making test errors and executive function in schizophrenia and depression",
        "Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis",
        "Relationship between movement planning and psychopathology profiles in schizophrenia",
        "Psychomotor slowing in schizophrenia",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory reflex system in antipsychotic naive first episode psychosis",
        "The brief psychiatric rating scale",
        "Spatial and temporal parameters of gait disturbances in schizophrenic patients",
        "Patterns of cognitive ageing",
        "Structural equation modeling with the SmartPLS",
        "Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway",
        "IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome",
        "The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: A study with functional magnetic resonance imaging",
        "Motor control and aging: Links to age-related brain structural, functional and biochemical effects",
        "A new schizophrenia model: immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "Eotaxin, an endogenous Cognitive Deteriorating Chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients",
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Motor symptoms and schizophrenia",
        "A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Asahi Glass Foundation",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}